205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-84.11%
Negative net income growth while MRVL stands at 5309.05%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-18.09%
Both reduce yoy D&A, with MRVL at -9.82%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
113.04%
Well above MRVL's 99.61% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-114.20%
Both reduce yoy usage, with MRVL at -148.09%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
39.50%
Inventory shrinking or stable vs. MRVL's 228.72%, indicating lean supply management. David Dodd would confirm no demand shortfall.
No Data
No Data available this quarter, please select a different quarter.
-108.16%
Both reduce yoy usage, with MRVL at -97.70%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-23.53%
Both negative yoy, with MRVL at -109.88%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-77.55%
Both yoy CFO lines are negative, with MRVL at -20.35%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
44.16%
CapEx growth well above MRVL's 15.16%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
83.97%
Purchases well above MRVL's 89.56%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
287.30%
We have some liquidation growth while MRVL is negative at -78.45%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
128.52%
Investing outflow well above MRVL's 52.58%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
20.00%
We slightly raise equity while MRVL is negative at -49.27%. John Neff sees competitor possibly preserving share count or buying back shares.
73.83%
Buyback growth of 73.83% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.